4 semaglutide In the OASIS phase 3 trial, once-daily oral at a dose of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or Losing weight and keeping it off can lessen the many health risks that come with obesity Another Weight-Loss Trial Win for
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12

























